We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms
News

Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms

Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms
News

Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Nematode worms treated with lithium show a 46 percent increase in lifespan, raising the tantalizing question of whether humans taking the mood affecting drug are also taking an anti-aging medication. Results of the Buck Institute study, led by faculty member Gordon J. Lithgow, PhD, are currently published online in the Journal of Biological Chemistry.

Lithium has been used to treat mood affective disorders, including bipolar disease for decades. While the drug has been shown to protect neurons, the underlying mechanism of its therapeutic action is not understood. In humans, lithium’s therapeutic range is very limited and the drug has serious side effects.

The research provides a novel genetic approach to understanding how lithium works and highlights the utility of using the nematode C. elegans as a research subject in the field of “pharmacogenetics”. Pharmocogenetics involves the study of genetic factors that influence an organism’s reaction to a drug.

In the study, scientists discovered that longevity was increased in the worms when the lithium “turned down” the activity of a gene that modulates the basic structure of chromosomes.

Lithgow believes that lithium impacts many genes. “Understanding the genetic impact of lithium may allow us to engineer a therapy that has the same lifespan extending benefits,” said Lithgow. “One of the larger questions is whether the lifespan extending benefits of the drug are directly related to the fact that lithium protects neurons.”

The process of normal aging in humans is intrinsically linked to the onset of neurodegenerative disease. However, the cellular changes and events due to aging that impact neurodegeneration are not yet understood said Lithgow. Studies involving compounds such as lithium could provide breakthroughs in the attempt to understand the biomedical link between aging and disease. Lithgow and his lab are now surveying tens of thousands of compounds for affects on aging.

The study highlights the efficacy of using C. elegans as a new way of studying drug toxicity and genetic impacts of compounds currently in drug development or already in use in humans. “The use of simple model organisms with well developed genetic tools can speed the identification of molecular targets,” said Lithgow. “This could facilitate the development of improved therapies for diseases.”

The paper can be accessed at http://www.jbc.org/cgi/content/abstract/M705028200v1

Advertisement